top of page

Rare & Complex Disease

Image by National Cancer Institute

At Phronetik, we leverage NGS to uncover the genetic roots of rare diseases, transforming diagnosis and treatment. Our NGS technology efficiently sequences DNA, identifying novel variations that traditional methods often miss, ensuring early and accurate diagnoses. Our capability to analyze multiple genes simultaneously at a lower cost makes us ideal for tackling complex diseases. By accelerating the development of targeted therapies, we enhance disease understanding and foster innovative treatments for rare and complex disorders.​

Related NGS Solutions

  • Clinical Whole Exome Sequencing

  • Target Region Sequencing

  • Whole Transcriptome Sequencing (WTS)

  • Whole Genome Bisulfite Sequencing (WGBS)

  • Reduced-Representation Bisulfite Sequencing (RRBS)

  • RNA Immunoprecipitation Sequencing (RIP-seq)

  • Chromatin Immunoprecipitation Sequencing (ChIP-seq)

More Applications

bottom of page